Previous 10 | Next 10 |
3 Best Penny Stocks to Add to Your Watchlist Right Now With another day of buying and selling penny stocks, there is a lot that investors need to understand. For one, we are once again seeing some bearish sentiment across the board. While it is not nearly as great as the previous tr...
Kaival Brands Innovations Group KAVL+51% on distribution deal with Philip Morris affiliate. National Vision Holdings EYE +14% on addition to SmallCap 600. Oracle ORCL +11% after reporting 'solid' Q4 despite economic headwinds. loanDepot (LDI) +8%. Continental Resource...
Day One Biopharmaceuticals (DAWN) +81% announces positive initial data from pivotal FIREFLY-1 trial of Tovorafenib (DAY101) in relapsed pediatric low-grade Glioma. Redbox Entertainment (RDBX) +30%. Ekso Bionics Holdings (EKSO) +22% receives FDA clearance to market its EksoNR Robotic...
The stock market was experiencing a frothy Friday on the last trading day of the week, but 23andMe Holding (NASDAQ: ME) was a bit of a wallflower at the party. As of 1:30 p.m. ET , the genetic testing and research specialist's shares were up only incrementally, at a rate well behind...
23andMe Holding Co. (ME) Q4 2022 Earnings Conference Call May 26, 2022 04:30 PM ET Company Participants Wade Walke - Vice President of Investor Relations Anne Wojcicki - Co-Founder and Chief Executive Officer Kenneth Hillan - Chief Therapeutics Officer Steve Schoch - Chief Financial Officer C...
23andMe press release (NASDAQ:ME): Q4 GAAP EPS of -$0.16 misses by $0.01. Revenue of $100.56M (+13.5% Y/Y) misses by $2.23M. FY2023 Guidance: Revenue guidance for FY2023, which will end on March 31, 2023, is projected to be in the range of $260 to $280 million, with a net loss in the ran...
Achieved FY2022 financial guidance Fourth quarter and full year revenues of $101 million and $272 million representing 14% and 11% increases over prior year, respectively New genomic health services expected in FY2023 Webcast today, May 26, 2022, at 4:30 p.m. Eastern Tim...
23andMe (NASDAQ:ME) FQ4 consensus EPS estimate is -$0.12 and consensus revenue estimate is $102.79M. ME is scheduled to announce FQ4 earnings results tomorrow, May 26, after market close. Seeking Alpha's Quant rating system has given the stock a Sell rating, having said ME is o...
ADSK, AEO, COST, DELL, DOMO, FTCH, GPS, LGF.A, LIZI, MAXN, ME, MRVL, RRGB, SUMO, SVM, TARO, ULTA, VMW, WDAY, ZS For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Thursday's close
Quarterhill Appoints John Karnes as CFO Canada NewsWire TORONTO , May 24, 2022 /CNW/ - Quarterhill Inc. ("Quarterhill" or "the Company") (TSX: QTRH) (OTCQX: QTRHF) announces that John Karnes has been appointed Chief Financial Officer ("CFO") of the Co...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial resu...
SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading genetic health and biopharmaceutical company, in collaboration with 20 lung cancer advocacy organizations, today announced a new study to help advance research in lung cancer. The focus of the Lun...